VANCOUVER, British Columbia – May 14, 2026 – EnWave Corporation (TSX-V:ENW | FSE:E4U), a global leader in vacuum microwave dehydration technology, has announced the date for its second quarter financial results announcement and subsequent investor conference call. The company will report its financial results for the second quarter ended March 31, 2026, after market close on Thursday, May 21, 2026.
The detailed financial statements and the accompanying Management’s Discussion and Analysis (MD&A) will be made available to the public on SEDAR at www.sedarplus.ca, as well as on EnWave’s corporate website. Investors and interested parties will have the opportunity to delve into the company’s performance during the second fiscal quarter.
Investor Conference Call Details
Following the release of its financial results, EnWave has scheduled an investor conference call for Friday, May 22, 2026. The call is set to commence at 7:00 a.m. Pacific Time, which corresponds to 10:00 a.m. Eastern Time. This session will provide a platform for the company’s leadership to discuss the Q2 2026 financial performance and outline the company’s business outlook.
Leading the discussion will be Brent Charleton, Chief Executive Officer, and Dylan Murray, Chief Financial Officer. They will present EnWave’s second quarter results and engage with participants during a dedicated question and answer period. This call is a key opportunity for stakeholders to gain insights into the company’s strategic direction and operational achievements.
Conference Call Access Information:
- Date: May 22, 2026
- Time: 7:00 a.m. PST / 10:00 a.m. EST
- Participant Access (Toll-Free): 1-877-407-2988
- Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=SUEZFGxE
About EnWave Corporation
EnWave Corporation is recognized as a global innovator and leader in the field of vacuum microwave dehydration. Headquartered in Delta, British Columbia, the company has cultivated a substantial intellectual property portfolio and refined its proprietary Radiant Energy Vacuum (REV™) technology. This technology has been instrumental in transforming an innovative concept into a reliable, scalable, and efficient drying solution for diverse industries, including food, pharmaceuticals, and cannabis. EnWave’s REV™ technology reportedly offers significant advantages over traditional drying methods in terms of efficiency, capacity, product quality, and cost-effectiveness.
The company operates through a licensing model, partnering with over fifty entities across twenty-four countries and five continents. These licensed partners leverage EnWave’s technology to develop novel snacks and ingredients, enhance the quality and consistency of existing products, streamline operations, and accelerate market entry. EnWave’s business strategy centers on establishing royalty-bearing commercial licenses with food producers seeking superior drying solutions compared to freeze-drying, rack-drying, and air-drying. The benefits for these partners include the creation of innovative new products, achieving optimal moisture levels up to seven times faster, and improving product attributes such as taste, texture, color, and nutritional value.
Further information about EnWave Corporation can be found on its website at EnWave.net.
Contact Information
For inquiries regarding EnWave Corporation’s financial results or business operations, interested parties can contact:
- Brent Charleton, CFA
President and CEO
Phone: +1 (778) 378-9616
Email: [email protected] - Dylan Murray, CPA, CA
CFO
Phone: +1 (778) 870-0729
Email: [email protected]
Forward-Looking Information Statement: This press release may contain forward-looking information based on management’s current expectations, estimates, and projections. Statements concerning the company’s growth strategy, product development, market position, anticipated expenditures, and expected synergies are considered forward-looking. The accuracy of third-party claims and market information referenced in this release is not guaranteed, as EnWave did not conduct the original primary research. These statements are not guarantees of future performance and involve inherent risks, uncertainties, and assumptions. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider is responsible for the adequacy or accuracy of this release.
